Showing results (1611-1620 of 1,711) with videos related to

Sort By:
Pageof 172
Frontiers in Bioscience (Landmark Edition)|March 2, 2020
Low-cost preventive screening using carotid ultrasound in patients with diabetesVijay Viswanathan, Ankush D Jamthikar, Deep Gupta, et al.
Diabetes Care|July 8, 2021
The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58Ofri Mosenzon, Stephen D Wiviott, Hiddo J L Heerspink, et al.
JACC. Cardiovascular Interventions|September 10, 2021
3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent ImplantationRoxana Mehran, Davide Cao, Dominick J Angiolillo, et al.
ESC Heart Failure|September 15, 2025
Empagliflozin after myocardial infarction with or without diabetes and chronic kidney disease: Insights from EMPACT-MIFrancesco Fioretti, Javed Butler, Jacob A Udell, et al.
The New England Journal of Medicine|March 17, 2015
Long-term use of ticagrelor in patients with prior myocardial infarctionMarc P Bonaca, Deepak L Bhatt, Marc Cohen, et al.
Journal of the American Heart Association|December 21, 2018
Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS-TIMI 54Marc P Bonaca, Stephen D Wiviott, David A Morrow, et al.
The New England Journal of Medicine|March 12, 2013
Effect of platelet inhibition with cangrelor during PCI on ischemic eventsDeepak L Bhatt, Gregg W Stone, Kenneth W Mahaffey, et al.
Diabetes Care|August 23, 2022
Dapagliflozin and Prevention of Kidney Disease Among Patients With Type 2 Diabetes: Post Hoc Analyses From the DECLARE-TIMI 58 TrialOfri Mosenzon, Itamar Raz, Stephen D Wiviott, et al.
The Lancet. Diabetes & Endocrinology|February 17, 2025
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trialRahul Aggarwal, Deepak L Bhatt, Michael Szarek, et al.
European Journal of Heart Failure|December 26, 2024
Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre-specified analysis of the EMPACT-MI trialMark C Petrie, Jacob A Udell, Stefan D Anker, et al.
Pageof 172